Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
News
General Healthcare
1
Mins
30th November 2017
Introducing the European Medical Journal 2.4
United Kingdom, November 30, 2017: The team at the European Medical Journal is proud to present the latest edition of their flagship publication EMJ 2.4.
General Healthcare
3
Mins
30th November 2017
Potential
Way back at the beginning of the year, when I was asked to create content and a schedule for the Future Leaders blog posts, I decided that I would write…
Innovations
2
Mins
30th November 2017
Cristal Therapeutics Awarded €2.5 Million Horizon 2020 Grant to Advance Its CriPec®-docetaxel Through Phase 2 Trials
Cristal Therapeutics Awarded €2.5 Million Horizon 2020 Grant to Advance Its CriPec®-docetaxel Through Phase 2 Trials
Oncology
2
Mins
30th November 2017
SOTIO Broadens Its Phase II Clinical Trial Program in Ovarian Cancer
Prague, Czech Republic, 28 November, 2017 – SOTIO, a biotechnology company owned by the PPF Group, today announced the enrollment of the first patient…
Neurology
3
Mins
30th November 2017
Orchard Therapeutics Announces Extension of its Collaboration with Manchester University to Include Sanfilippo Syndrome Type B
London & Manchester, UK, 27 November, 2017 – Orchard Therapeutics Limited (“Orchard”), a clinical-stage biotechnology company…
Allergy & Immunology
1
Mins
28th November 2017
Gene Associated with Peanut Allergy Revealed
A GENE previously identified as playing a role in eczema, asthma, and allergic rhinitis has been pinpointed as being associated with the incidence of…
Allergy & Immunology
1
Mins
28th November 2017
Exposure to Dogs Reduces Risk of Childhood Eczema and Asthma
EXPOSURE of pregnant mothers to dogs, as well as early contact between children and canine-specific bacteria, may reduce the risk of childhood eczema and…
Oncology
1
Mins
23rd November 2017
Treatment Approval Broadened to Include Earlier Stage Prostate Cancer Patients
AN UNMET need in prostate cancer patients could be filled following the extension of European Commission (EC) marketing authorisation of the combination…
Loading posts...
« Previous
1
…
197
198
199
200
201
…
333
Next »